Volume 226, Issue Supplement_2
15 August 2022
Cover image
Cover image
Netter illustration used with permission of Elsevier Inc. All rights reserved. https://protect-de.mimecast.com/s/ETf9C99JMYtzYG8AgsP2fIG?domain=netterimages.com
ISSN 0022-1899
EISSN 1537-6613
Issue navigation
Volume 226, Issue Supplement_2, 15 August 2022
Respiratory Syncytial Virus Disease Among US Infants
Supplement Articles
The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S143–S147, https://doi.org/10.1093/infdis/jiac211
All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S148–S153, https://doi.org/10.1093/infdis/jiac244
Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S154–S163, https://doi.org/10.1093/infdis/jiac120
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S164–S174, https://doi.org/10.1093/infdis/jiac185
Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S175–S183, https://doi.org/10.1093/infdis/jiac220
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S184–S194, https://doi.org/10.1093/infdis/jiac155
A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S195–S212, https://doi.org/10.1093/infdis/jiac201
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S213–S224, https://doi.org/10.1093/infdis/jiac203
Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S225–S235, https://doi.org/10.1093/infdis/jiac172
Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S236–S245, https://doi.org/10.1093/infdis/jiac183
To describe the burden of illness from respiratory syncytial virus (RSV) among infants, we systematically reviewed literature and performed a systematic analysis on quality of life and health utilities attributable to this disease.
Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S246–S254, https://doi.org/10.1093/infdis/jiac127
The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999–2018
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S255–S266, https://doi.org/10.1093/infdis/jiac187
Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S267–S281, https://doi.org/10.1093/infdis/jiac226
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S282–S292, https://doi.org/10.1093/infdis/jiac216
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States
The Journal of Infectious Diseases, Volume 226, Issue Supplement_2, 15 August 2022, Pages S293–S299, https://doi.org/10.1093/infdis/jiac164
